View source for BEAUTIFUL study fails to meet primary endpoint but demonstrates that heart rates can safely be reduced with Ivabradine

Jump to navigation Jump to search

You do not have permission to edit this page, for the following reason:

The action you have requested is limited to users in the group: Users.


You can view and copy the source of this page.

Return to BEAUTIFUL study fails to meet primary endpoint but demonstrates that heart rates can safely be reduced with Ivabradine.